These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 823318)

  • 1. Portacaval shunt in siblings for type I glycogenosis.
    Liebschutz D; Soper RT
    J Pediatr Surg; 1976 Aug; 11(4):557-61. PubMed ID: 823318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage disease: new approaches to therapy.
    Crigler JF; Folkman J
    Ciba Found Symp; 1977; (55):331-51. PubMed ID: 95940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portacaval transposition in the treatment of glycogen-storage disease.
    Riddell AG; Davies RP; Clark AD
    Lancet; 1966 Nov; 2(7474):1146-8. PubMed ID: 4162539
    [No Abstract]   [Full Text] [Related]  

  • 5. Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Choi Y; Yi NJ; Ko JS; Moon JS; Suh SW; Lee JM; Jeong JH; Kim H; Lee HW; Lee KW; Suh KS
    Transplantation; 2016 Mar; 100(3):585-92. PubMed ID: 26360666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of portacaval shunt in glycogen storage disease type 1B.
    Corbeel L; Van Lierde S; Jaeken J
    Eur J Pediatr; 2000 Apr; 159(4):268-72. PubMed ID: 10789932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of dietary therapy and portacaval shunt in the management of a patient with type Ib glycogen storage disease.
    Borowitz SM; Greene HL; Gay JC; Neblett WW
    J Pediatr Gastroenterol Nutr; 1987; 6(4):635-9. PubMed ID: 3123638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt.
    Starzl TE; Porter KA; Francavilla A; Iwatsuki S
    Lancet; 1983 Aug; 2(8347):424-6. PubMed ID: 6135912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portacaval shunt as treatment for glycogenosis Ib.
    Ozsoylu S
    Am J Dis Child; 1986 Apr; 140(4):324. PubMed ID: 3456699
    [No Abstract]   [Full Text] [Related]  

  • 12. [Terminolateral portacaval shunt does not prevent hepatic regeneration after 65% hepatectomy in the dog. Value of parenteral nutritional support].
    Piccolboni D; Saint-Aubert B; Andriguetto PC; Jahed AM; Ould Said H; Astre C; Vic P; Bories P; Hoyeux J
    J Chir (Paris); 1982 Oct; 119(10):603-11. PubMed ID: 6816806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy.
    Sokal EM; Lopez-Silvarrey A; Buts JP; Otte JB
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):465-7. PubMed ID: 8315558
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
    Burr IM; O'Neill JA; Karzon DT; Howard LJ; Greene HL
    J Pediatr; 1974 Dec; 85(6):792-5. PubMed ID: 4213651
    [No Abstract]   [Full Text] [Related]  

  • 15. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.
    Folkman J; Philippart A; Tze WJ; Crigler J
    Surgery; 1972 Aug; 72(2):306-14. PubMed ID: 4626293
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
    Corbeel L; Hue L; Lederer B; De Barsy T; Van den Berghe G; Devlieger H; Jaeken J; Bracke P; Eeckels R
    Pediatr Res; 1981 Jan; 15(1):58-61. PubMed ID: 6259580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycogenosis type I. Therapy (author's transl)].
    López MJ; Escribano A; Brines J; Colomer J
    An Esp Pediatr; 1980 Aug; 13(8):689-99. PubMed ID: 6933881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Portacaval anastomosis in 2 cases of homozygote familial hypercholesterolemia].
    Guibaud P; Cartailhac Y; Smit G; de Parscau L; Louis D
    Pediatrie; 1986 Sep; 41(6):453-9. PubMed ID: 3808847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.
    Corbeel L; Boogaerts M; Van den Berghe G; Everaerts MC; Marchal G; Eeckels R
    Eur J Pediatr; 1983; 140(3):273-5. PubMed ID: 6578929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of glycogenosis type III with total parenteral nutrition, continuous intragastric infusion and D-thyroxine].
    Böhles H; Dick W; Scharf J
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):160-1. PubMed ID: 6813261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.